← Leaderboards
Subhra Mohapatra
James A. Haley Va Medical Center
$1,342,562
Attributed
$3,021,292
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $750K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,021,292 · 3
VA$0 · 7
By mechanism
R01$2,862,463 · 2
R41$158,829 · 1
I01$0 · 5
IK6$0 · 1
IS1$0 · 1
Top collaborators
- Shyam S Mohapatra19 shared
- Paula C Bickford2 shared
Most similar at James A. Haley Va Medical Center
Same institution · by research overlap
- Shyam S Mohapatra$5,225,407
Others in their field
Top investigators on “Mouse Model”
- Dennis R. Burton · Scripps Research Institute$280,661,242
- David Heimbrook · Leidos Biomedical Research, Inc.$84,491,283
- Kc Kent Lloyd · University Of California At Davis$74,285,556
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Stanley B Prusiner · University Of California San Francisco$61,905,394
- Ed Lein · Allen Institute$59,425,748
Research focus
Mouse ModelInnovationCellsCollaborationsInflammationIn VivoBasePharmaceutical PreparationsProgramsMesenchymal Stem CellsMalignant NeoplasmsNanoStem Cell TherapyProteinsReagentReportingSmall Interfering RnaIn VitroMalignant Neoplasm Of LungTreatment Efficacy3-DimensionalReceptorCell TherapyClinical Trials
Grant awards (33)
Molecular Targets Modulating Neuro COVID Sequelae Linked to Tauopathy$734,995
R01 · FY2025 · AG · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2025 · VA · contact PI
Anti-inflammatory and hMSC combination therapy for traumatic brain injury$0
I01 · FY2025 · VA · contact PI
Nanoformulations for Respiratory Infections$0
I01 · FY2025 · VA
Molecular Targets Modulating Neuro COVID Sequelae Linked to Tauopathy$749,994
R01 · FY2024 · AG · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2024 · VA · contact PI
Anti-inflammatory and hMSC combination therapy for traumatic brain injury$0
I01 · FY2024 · VA · contact PI
COVID-19: SARS-CoV-2 Neutralizing Agents$0
I01 · FY2023 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2023 · VA · contact PI
Anti-inflammatory and hMSC combination therapy for traumatic brain injury$0
I01 · FY2023 · VA · contact PI
Tumor targeted engineered stem cells for treatment of lung cancer$0
I01 · FY2022 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2022 · VA · contact PI
COVID-19: SARS-CoV-2 Neutralizing Agents$0
I01 · FY2022 · VA · contact PI
Tumor targeted engineered stem cells for treatment of lung cancer$0
I01 · FY2021 · VA · contact PI
COVID-19: SARS-CoV-2 Neutralizing Agents$0
I01 · FY2021 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2021 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2020 · VA · contact PI
Tumor targeted engineered stem cells for treatment of lung cancer$0
I01 · FY2020 · VA · contact PI
Tumor targeted engineered stem cells for treatment of lung cancer$0
I01 · FY2019 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2019 · VA · contact PI
Combined Nano and Cell therapy for the Treatment of TBI$0
I01 · FY2019 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2018 · VA · contact PI
Combined Nano and Cell therapy for the Treatment of TBI$0
I01 · FY2018 · VA · contact PI
Tumor targeted engineered stem cells for treatment of lung cancer$0
I01 · FY2018 · VA · contact PI
Combined Nano and Cell therapy for the Treatment of TBI$0
I01 · FY2017 · VA · contact PI
ShEEP Request for High Content Analysis Platform for Cellular Imaging$0
IS1 · FY2016 · VA · contact PI
Combined Nano and Cell therapy for the Treatment of TBI$0
I01 · FY2016 · VA · contact PI
An Integrated Nano-Cell Delivery Platform of Theranostics for Lung Cancers$286,998
R01 · FY2014 · CA
An Integrated Nano-Cell Delivery Platform of Theranostics for Lung Cancers$193,703
R01 · FY2013 · CA
An Integrated Nano-Cell Delivery Platform of Theranostics for Lung Cancers$295,874
R01 · FY2012 · CA
An Integrated Nano-Cell Delivery Platform of Theranostics for Lung Cancers$295,874
R01 · FY2011 · CA
An Integrated Nano-Cell Delivery Platform of Theranostics for Lung Cancers$305,025
R01 · FY2010 · CA
Targeting of Curcumin-genistein nanocomplexes for Treatment of Prostate Cancer$158,829
R41 · FY2009 · CA · contact PI